Exact Mass: 528.2311
Exact Mass Matches: 528.2311
Found 333 metabolites which its exact mass value is equals to given mass value 528.2311
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Satratoxin H
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
Dutasteride
Dutasteride belongs to a class of drugs called 5-alpha-reductase inhibitors, which block the action of the 5-alpha-reductase enzymes that convert testosterone into dihydrotestosterone (DHT). Finasteride also belongs to this group, but while dutasteride inhibits both isoforms of 5-alpha reductase, finasteride inhibits only one. Even so, a clinical study done by GlaxoSmithKline, the EPICS trial, did not find dutasteride to be more effective than finasteride in treating BPH. [Wikipedia] G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Felotaxel
Ibutamoren
Methyl 3beta-acetoxy-6-hydroxy-1-oxomeliac-14-enoate
2alpha-acetoxy-9alpha-benzoyloxy-5alpha,7beta,10beta,15-tetrahydroxy-11(15->1)-abeotaxa-4(20),11-dien-13-one|2??-Acetoxy-9??-benzoyloxy-5??,7??,10??,15-tetrahydroxy-11(15鈥樏傗垎1)-abeotaxa-4(20),11-dien-13-one
(?)-2-(Acetyloxy)-8-(furan-3-yl)dodecahydro-3,3,5,7a-tetramethyl-10,13-dioxo-1,5-methano-2H,8H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-4-acetic acid methyl ester
1,3,6,8-Tetramethyl-4,5-divinyl-9,10-dihydro-1,3-biphenanthrene-2,2,7,7-tetrol
3-Xyloside-(3beta,14beta)-3,14-Dihydroxy-19-oxobufa-5,7,20,22-tetraenolide
Dutasteride
G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Lurasidone HCl
Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is an antagonist of both dopamine D2 and 5-HT7 with IC50s of 1.68 and 0.495 nM, respectively. Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is also a partial agonist of 5-HT1A receptor with an IC50 of 6.75 nM.
methyl (2R)-2-(acetyloxy)-2-[(1S,3S,7R,8R,9R,12S,13R)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate
Ala Glu Phe Tyr
Ala Glu Tyr Phe
Ala Phe Glu Tyr
Ala Phe Tyr Glu
Ala Tyr Glu Phe
Ala Tyr Phe Glu
Cys Phe Phe Ile
Cys Phe Phe Leu
Cys Phe Ile Phe
Cys Phe Leu Phe
Cys His Asn Arg
Cys His Arg Asn
Cys Ile Phe Phe
Cys Leu Phe Phe
Cys Asn His Arg
Cys Asn Arg His
Cys Arg His Asn
Cys Arg Asn His
Asp Phe Phe Thr
Asp Phe Thr Phe
Asp Thr Phe Phe
Glu Ala Phe Tyr
Glu Ala Tyr Phe
Glu Phe Ala Tyr
Glu Phe Phe Ser
Glu Phe His Pro
Glu Phe Pro His
Glu Phe Ser Phe
Glu Phe Tyr Ala
Glu His Phe Pro
Glu His Ile Met
Glu His Leu Met
Glu His Met Ile
Glu His Met Leu
Glu His Pro Phe
Glu Ile His Met
Glu Ile Met His
Glu Leu His Met
Glu Leu Met His
Glu Met His Ile
Glu Met His Leu
Glu Met Ile His
Glu Met Leu His
Glu Pro Phe His
Glu Pro His Phe
Glu Ser Phe Phe
Glu Tyr Ala Phe
Glu Tyr Phe Ala
Phe Ala Glu Tyr
Phe Ala Tyr Glu
Phe Cys Phe Ile
Phe Cys Phe Leu
Phe Cys Ile Phe
Phe Cys Leu Phe
Phe Asp Phe Thr
Phe Asp Thr Phe
Phe Glu Ala Tyr
Phe Glu Phe Ser
Phe Glu His Pro
Phe Glu Pro His
Phe Glu Ser Phe
Phe Glu Tyr Ala
Phe Phe Cys Ile
Phe Phe Cys Leu
Phe Phe Asp Thr
Phe Phe Glu Ser
Phe Phe Ile Cys
Phe Phe Leu Cys
Phe Phe Ser Glu
Phe Phe Thr Asp
Phe His Glu Pro
Phe His Pro Glu
Phe Ile Cys Phe
Phe Ile Phe Cys
Phe Leu Cys Phe
Phe Leu Phe Cys
Phe Pro Glu His
Phe Pro His Glu
Phe Ser Glu Phe
Phe Ser Phe Glu
Phe Thr Asp Phe
Phe Thr Phe Asp
Phe Tyr Ala Glu
Phe Tyr Glu Ala
His Cys Asn Arg
His Cys Arg Asn
His Glu Phe Pro
His Glu Ile Met
His Glu Leu Met
His Glu Met Ile
His Glu Met Leu
His Glu Pro Phe
His Phe Glu Pro
His Phe Pro Glu
His Ile Glu Met
His Ile Met Glu
His Leu Glu Met
His Leu Met Glu
His Met Glu Ile
His Met Glu Leu
His Met Ile Glu
His Met Leu Glu
His Asn Cys Arg
His Asn Arg Cys
His Pro Glu Phe
His Pro Phe Glu
His Arg Cys Asn
His Arg Asn Cys
Ile Cys Phe Phe
Ile Glu His Met
Ile Glu Met His
Ile Phe Cys Phe
Ile Phe Phe Cys
Ile His Glu Met
Ile His Met Glu
Ile Met Glu His
Ile Met His Glu
Leu Cys Phe Phe
Leu Glu His Met
Leu Glu Met His
Leu Phe Cys Phe
Leu Phe Phe Cys
Leu His Glu Met
Leu His Met Glu
Leu Met Glu His
Leu Met His Glu
Met Glu His Ile
Met Glu His Leu
Met Glu Ile His
Met Glu Leu His
Met His Glu Ile
Met His Glu Leu
Met His Ile Glu
Met His Leu Glu
Met Ile Glu His
Met Ile His Glu
Met Leu Glu His
Met Leu His Glu
Asn Cys His Arg
Asn Cys Arg His
Asn His Cys Arg
Asn His Arg Cys
Asn Arg Cys His
Asn Arg His Cys
Pro Glu Phe His
Pro Glu His Phe
Pro Phe Glu His
Pro Phe His Glu
Pro His Glu Phe
Pro His Phe Glu
Pro Ser Tyr Tyr
Pro Tyr Ser Tyr
Pro Tyr Tyr Ser
Arg Cys His Asn
Arg Cys Asn His
Arg His Cys Asn
Arg His Asn Cys
Arg Asn Cys His
Arg Asn His Cys
Ser Glu Phe Phe
Ser Phe Glu Phe
Ser Phe Phe Glu
Ser Pro Tyr Tyr
Ser Tyr Pro Tyr
Ser Tyr Tyr Pro
Thr Asp Phe Phe
Thr Phe Asp Phe
Thr Phe Phe Asp
Tyr Ala Glu Phe
Tyr Ala Phe Glu
Tyr Glu Ala Phe
Tyr Glu Phe Ala
Tyr Phe Ala Glu
Tyr Phe Glu Ala
Tyr Pro Ser Tyr
Tyr Pro Tyr Ser
Tyr Ser Pro Tyr
Tyr Ser Tyr Pro
Tyr Tyr Pro Ser
Tyr Tyr Ser Pro
METHYL2,4-DIMETHYL-5-(TERT-BUTOXYCARBONYL)-3-PYRROLE PROPIONATE
(+)-4,5-Bis[hydroxy(diphenyl)methyl]-2-methyl-2-phenyl-1,3-dioxolane
(3aR,4R,7S,7aS)-rel-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione hydrochloride (1:1)
1-[(1R)-1-(1-ethylsulfonyl-4-piperidinyl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-3-indolecarboxamide
Lurasidone Hydrochloride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is an antagonist of both dopamine D2 and 5-HT7 with IC50s of 1.68 and 0.495 nM, respectively. Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is also a partial agonist of 5-HT1A receptor with an IC50 of 6.75 nM.
[(2S,3S,4S,6R)-6-[[(1S,3R,4R)-3-ethyl-3,4,10,12-tetrahydroxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-dimethylazanium
(6R,11R,13R,14S,15S,21E,23S,27R)-27-hydroxy-23-[(1S)-1-hydroxyethyl]-9,15-dimethylspiro[4,12,17,24-tetraoxapentacyclo[21.3.1.113,16.06,11.06,15]octacosa-1,9,19,21-tetraene-14,2-oxirane]-3,18-dione
methyl (2R)-2-acetyloxy-2-[(1S,3S,7R,8R,9R,12S,13S)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate
(1R,3aS,3bS,5aR,9aR,9bR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (Z)-tridec-9-enoate
(1E,6R,11R,13R,14S,15S,19E,21E,23S,27R)-27-hydroxy-23-[(1S)-1-hydroxyethyl]-9,15-dimethylspiro[4,12,17,24-tetraoxapentacyclo[21.3.1.113,16.06,11.06,15]octacosa-1,9,19,21-tetraene-14,2-oxirane]-3,18-dione
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
4,5'-diethenyl-1',3,6',8-tetramethyl-9',10'-dihydro-[1,3'-biphenanthrene]-2,2',7,7'-tetrol
3-(acetyloxy)-7-ethenyl-2,8a,9-trihydroxy-1,1,4a,7-tetramethyl-5,8-dioxo-octahydrophenanthren-4-yl benzoate
methyl (2r)-2-(acetyloxy)-2-[(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate
methyl 2-[(1r,2r,5r,6r,13r,14s,16r)-14-(acetyloxy)-6-(furan-3-yl)-13-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate
(1'r,2s,3'r,8'r,12'e,15'r,17's,18's,25's,26's,28'r)-28'-hydroxy-5',13',17',26'-tetramethyl-2',10',16',24',29'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.1¹⁵,¹⁸.0³,⁸.0⁸,²⁶]nonacosane]-4',12',19',21'-tetraene-11',23'-dione
methyl 2-[(2s,3r,5r,6r,10s,13s,14r,16s)-3-(acetyloxy)-6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-11-en-16-yl]acetate
(3r,5s,7r,10r,12r,14s,15s,18r,19r,22s,23r)-10,22-dihydroxy-7,18-dimethyl-9-oxo-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-ene-14-carbaldehyde
methyl (1r,3s,6s,7s,10r,11r)-10-[(1r,6r)-6-[(acetyloxy)methyl]-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-6-(furan-3-yl)-7,11-dimethyl-4-oxo-2,5-dioxatricyclo[5.4.0.0¹,³]undecane-11-carboxylate
{2,6,6,14,19-pentamethyl-3,8,15,20-tetraoxo-7,16,18-trioxapentacyclo[12.6.1.0²,¹².0⁵,¹⁰.0¹⁷,²¹]henicosa-4,10-dien-11-yl}methyl 3-methylbutanoate
(1s,3r,7r,10s,13r,14s,18r,19r)-1-hydroxy-9,9,18-trimethyl-18-[(2s)-2-methyl-3-[(2z)-4-methyl-5-oxofuran-2-ylidene]propanoyl]-4,8,15-trioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁹]icosane-5,16-dione
methyl 2-[17-(acetyloxy)-9-(furan-3-yl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-15-yl]acetate
18'-(1-hydroxyethyl)-5',14',26'-trimethyl-2',7',11',17',24'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.0³,⁹.0⁶,⁸.0⁹,²⁶]octacosane]-4',13',19',21'-tetraene-12',23'-dione
3-{4-[4-ethoxy-6-(2-methoxy-2-oxoethyl)-5,5,7-trimethyl-6,7-dihydro-4h-1-benzofuran-2-yl]-2-(furan-3-yl)-3-methyl-6-oxo-2h-pyran-3-yl}propanoic acid
methyl 2-[(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-17-(acetyloxy)-9-(furan-3-yl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-15-yl]acetate
2α-acetoxy-9α-benzoyloxy-5α,7β,10β,15-tetra-hydroxy-11(15→1)-abeotaxa-4(20),11-dien-13-one
{"Ingredient_id": "HBIN005268","Ingredient_name": "2\u03b1-acetoxy-9\u03b1-benzoyloxy-5\u03b1,7\u03b2,10\u03b2,15-tetra-hydroxy-11(15\u21921)-abeotaxa-4(20),11-dien-13-one","Alias": "NA","Ingredient_formula": "C29H36O9","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3C(C2(CC1=O)C(C)(C)O)OC(=O)C)O)O)C)OC(=O)C4=CC=CC=C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "133","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-o-deacetylorthosiphol i
{"Ingredient_id": "HBIN009309","Ingredient_name": "3-o-deacetylorthosiphol i","Alias": "NA","Ingredient_formula": "C29H36O9","Ingredient_Smile": "CC(=O)OC1C(C(C2CC(C3(C(C2(C1OC(=O)C4=CC=CC=C4)C)C(=O)CC(C3=O)(C)C=C)O)O)(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4759","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}